China Universal Asset Management »

Prime Medicine shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Prime Medicine (PRME) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Prime Medicine

Tip: Access up to 7 years of quarterly data

All positions including Prime Medicine held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prime Medicine by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $170k 31k 5.54
2025-06-30 $65k 26k 2.47
2025-03-31 $52k 26k 1.99
2024-12-31 $81k 28k 2.92
2024-09-30 $89k 23k 3.87
2024-06-30 $73k 14k 5.14
2024-03-31 $157k 22k 7.00
2023-12-31 $100k 11k 8.86

More positions owned by China Universal Asset Management

Nvidia Corp Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Amazon.com Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Alphabet Inc-cl A Common Stock (GOOGL)
Meta Platforms Inc-class A Common Stock (META)
Netflix Common Stock (NFLX)
Tesla Common Stock (TSLA)
Amgen Common Stock (AMGN)
Gilead Sciences Common Stock (GILD)
Vertex Pharmaceuticals Common Stock (VRTX)
Alphabet Inc-cl C Common Stock (GOOG)
Palantir Technologies Inc-a Common Stock (PLTR)
Applovin Corp-class A Common Stock (APP)

View all positions for China Universal Asset Management

Top funds holding Prime Medicine

Alphabet
T. Rowe Price Investment Management
BlackRock
ARK Investment Management
Vanguard Group
Farallon Capital Management
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Casdin Capital
Woodline Partners
RA Capital Management
FMR
D. E. Shaw & Co
MWG Management
Geode Capital Management

View all funds holding Prime Medicine